Mevion nabs FDA OK for proton therapy system
Mevion Medical Systems has received 510(k) clearance from the U.S. Food and...Read more on AuntMinnie.comRelated Reading:
Mevion submits 510(k) to FDA for proton therapy system
Mevion touts scanning milestone
Mevion joins forces with MedPhoton
Mevion completes milestone installation
Mevion completes Fla. installation (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 3, 2018 Category: Radiology Source Type: news
Penn medicine | virtua strategic alliance brings first proton therapy to south Jersey
(University of Pennsylvania School of Medicine) Cancer care in South Jersey is about to enter a new era. Penn Medicine, in partnership with Virtua, announced plans to build a new proton facility on the campus of Virtua's acute care hospital, Virtua Voorhees. The new $35 million center, which will allow cancer patients to undergo cutting edge proton therapy in single-room treatments, is expected to be completed by 2020. It will be the first and only proton therapy center in South Jersey. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 14, 2017 Category: International Medicine & Public Health Source Type: news
Penn Medicine/Virtua strategic alliance brings first proton therapy to South Jersey
(University of Pennsylvania School of Medicine) Cancer care in South Jersey is about to enter a new era. Penn Medicine, in partnership with Virtua, announced plans to build a new proton facility on the campus of Virtua's acute care hospital, Virtua Voorhees. The new $35 million center, which will allow cancer patients to undergo cutting edge proton therapy in single-room treatments, is expected to be completed by 2020. It will be the first and only proton therapy center in South Jersey. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 14, 2017 Category: Cancer & Oncology Source Type: news
New $50M proton therapy center at UAB to begin work in 2018
The University of Alabama at Birmingham and Proton International have secured funding for the new UAB Proton Therapy Center.
The two entities expect to break ground on the $50 million facility, which will be the first proton therapy center in Alabama, in January 2018.
Construction on the two-story, 29,000-square-foot facility is expected to take two years.
Proton therapy is an advanced form of radiation treatment av ailable at only 25 locations in the United States.
According to UAB, it is… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 13, 2017 Category: American Health Source Type: news
7 medtech stories we missed this week: Nov. 17, 2017
[Image from unsplash.com]From Skyline Medical’s joint venture to Lensar receiving FDA clearance and CE Mark, here are seven medtech stories we missed this week but thought were still worth mentioning.
1. Skyline Medical launches JV deal with Helomics
Skyline Medical announced in a Nov. 15 press release that it has signed a joint venture agreement with Helomics. The agreement comes after a strategic collaboration between the companies that allows Skyline to reach more markets. The joint venture leverages the Helomics D-Chip platform to develop and market new approaches for personalized cancer diagnostics and care.
2.Â...
Source: Mass Device - November 17, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Diagnostics Food & Drug Administration (FDA) mHealth (Mobile Health) Neurological Neuromodulation/Neurostimulation Regenerative Medicine Regulatory/Compliance Research & Development Helomics InnerScope iReliev LensAR Inc. Source Type: news
Varian secures Japanese clearance for Halcyon
Varian Medical Systems has received clearance from the Japanese Ministry of...Read more on AuntMinnie.comRelated Reading:
Varian names new chief people officer
Varian's fiscal 2017 results hold steady
Varian takes orders for proton therapy system
French court denies Varian effort to block Accuray deal
Varian announces 1st patient treated with Halcyon (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 16, 2017 Category: Radiology Source Type: news
IBA posts revenue decreases in Q3
Proton therapy firm Ion Beam Applications (IBA) posted revenue decreases for...Read more on AuntMinnie.comRelated Reading:
IBA, Elekta join forces on software development
IBA posts half-year revenue increases
Philips, Varian, IBA partner on Singapore cancer center
IBA inks Va. installation deal
IBA to show updated synthesizer at SNMMI 2017 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 16, 2017 Category: Radiology Source Type: news
Hamlin proton therapy center gets OK, construction plans to be submitted
A planned cancer-fighting medical center in the $1 billion Hamlin community got the go ahead from Orange County on Nov. 1.
Construction plans will be submitted in the next few weeks for the 37,542-square-foot Provision Proton Therapy Center, project engineer Scott Gentry, principal of Orlando-based Kelly, Collins& Gentry Inc., told Orlando Business Journal. It's being developed by Provision Proton Center at Hamlin LLC, an entity related to Orlando-based Boyd Development Corp. and Knoxville, Tenn.-based … (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 1, 2017 Category: American Health Authors: Sarah Aslam Source Type: news
Varian Names New Chief People Officer, SVP HR
Terilyn Juarez Monroe named to replace retiring Wendy Scott
PALO ALTO, Calif., Oct. 30, 2017 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (NYSE: VAR) today announced it has named Terilyn Juarez Monroe as Chief People Officer, sen... Devices, Oncology, Personnel Varian Medical Systems, proton therapy, radiotherapy, radiosurgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 30, 2017 Category: Pharmaceuticals Source Type: news
Proton therapy for prostate cancer is advantageous to imrt according to new study
(Northwestern Memorial HealthCare) Proton therapy treatment for prostate cancer is associated with higher survival rates and decreased risk of complications compared to intensity-modulated radiation therapy (IMRT) according to a new study by researchers at the Northwestern Medicine Chicago Proton Center. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 25, 2017 Category: International Medicine & Public Health Source Type: news
Proton therapy may be better option for elderly patients with esophageal cancer
(Mayo Clinic) A study led by Mayo Clinic researchers has found that proton beam therapy, in combination with chemotherapy, prior to surgery, may be a better option than a combination using traditional radiation therapy techniques with chemotherapy when treating elderly patients with esophageal cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 24, 2017 Category: Cancer & Oncology Source Type: news
Proton therapy may be better option for elderly patients with esophageal cancer
CHICAGO ? A study led by Mayo Clinic researchers has found that proton beam therapy, in combination with chemotherapy, prior to surgery, may be a better option than a combination using traditional radiation therapy techniques with chemotherapy when treating elderly patients with esophageal cancer. Standard X-ray radiation therapy techniques include 3-D conformal radiation and intensity-modulated [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 24, 2017 Category: Databases & Libraries Source Type: news
Proton therapy lowers treatment side effects in pediatric head and neck cancer patients
(University of Pennsylvania School of Medicine) Pediatric patients with head and neck cancer can be treated with proton beam therapy (PBT) instead of traditional photon radiation, and it will result in similar outcomes with less impact on quality of life. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 23, 2017 Category: Cancer & Oncology Source Type: news
Northwestern Medicine Chicago Proton Center hosts 4th Annual PTCOG-NA Conference in Chicago
(Northwestern Memorial HealthCare) The Northwestern Medicine Chicago Proton Center will host over 200 leading clinicians, physicists and researchers in the growing field of proton therapy at the 4th Annual Particle Therapy Co-Operative Group North-America (PTCOG-NA) Conference, being held Oct. 23-25, 2017 at the Swiss ô tel Chicago. Conference participants will share the latest clinical, scientific and industrial developments in particle beam therapy, an advanced form of radiation therapy using beams of protons to destroy cancer cells and diseased tissue. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 19, 2017 Category: International Medicine & Public Health Source Type: news
IBA, Elekta join forces on software development
Proton therapy firm Ion Beam Applications (IBA) and radiation oncology vendor...Read more on AuntMinnie.comRelated Reading:
IBA posts half-year revenue increases
Elekta adds members to MR-Linac Consortium
Elekta promotes 21 studies at AAPM 2017
Elekta to install Bhutan's 1st linear accelerator
Philips, Varian, IBA partner on Singapore cancer center
IBA inks Va. installation deal (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 25, 2017 Category: Radiology Source Type: news
